Document Detail

Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.
MedLine Citation:
PMID:  15474338     Owner:  NLM     Status:  MEDLINE    
Angiogenesis is believed to play a critical role in cancer; however, antiangiogenic therapy has not been demonstrated to improve the survival of patients who have lung cancer. In this article, the evidence that supports a role for angiogenesis in the pathogenesis of lung cancer, trials of antiangiogenic agents in lung cancer performed to date, and the lessons learned from these studies are discussed.
Fiona H Blackhall; Frances A Shepherd
Related Documents :
16100648 - The evaluation of soluble fas and soluble fas ligand levels of bronchoalveolar lavage f...
9194028 - Role of tyrosine specific phosphorylation of cellular proteins, especially egf receptor...
9543288 - Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocauter...
19947998 - Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis assoc...
17637738 - Increased mitochondrial dna induces acquired docetaxel resistance in head and neck canc...
19894078 - Code status documentation in the outpatient electronic medical records of patients with...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Hematology/oncology clinics of North America     Volume:  18     ISSN:  0889-8588     ISO Abbreviation:  Hematol. Oncol. Clin. North Am.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-11     Completed Date:  2004-12-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8709473     Medline TA:  Hematol Oncol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1121-41, ix     Citation Subset:  IM    
Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX England, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inhibitors / therapeutic use*
Carcinoma, Non-Small-Cell Lung / blood supply,  drug therapy*
Carcinoma, Small Cell / blood supply,  drug therapy*
Clinical Trials as Topic
Lung Neoplasms / blood supply,  drug therapy*
Neovascularization, Pathologic / prevention & control
Protease Inhibitors / therapeutic use
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Protease Inhibitors; 0/Vascular Endothelial Growth Factor A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Angiogenesis and lymphangiogenesis of skin cancers.
Next Document:  Renal cell carcinoma: rationale and development of therapeutic inhibitors of angiogenesis.